Why Is Israel So Effective?
Executive Summary
IATI's Karen Mayer Rubenstein volunteers several reasons why this small country is so productive when it comes to R&D.
You may also be interested in...
Israel’s Medtech Looks To A Future Beyond Start-Ups
Israel’s life sciences industry drive is legendary, and the past year has been the best of a truly impressive decade, in terms of exits, M&A, IPOs and investments. With a thriving R&D base, the local life sciences and high-tech industries are about to move to the next level.
The Sustainability Stakes Are Rising: ‘We Cannot Recycle Our Way Out Of This’
The journey to Net Zero, described as ‘the defining issue of our time,’ will get harder in the coming decade. Failure to keep up the pressure will result in more long-term health conditions, increasing deaths and higher costs. The UK NHS is a Net Zero exemplar globally, but without a systemic approach, its compliance efforts could stutter.
UK Life Sciences Cautiously Upbeat For Investment Year Ahead – BioWales 2024
Favorable UK biopharma investment trends have been reported by the BioIndustry Association, but can medtech and healthtech share in the positivity? A roundtable at the BioWales in London 2024 event framed the outlook for non-pharma players.